COPAXEASE

Marca svizra · 641627 · Marca da pled · Stizzada

Inscripziun en il register

Numer da registraziun
641627
Numer da la dumonda
64309/2012
Status
Stizzada
Tip
Marca da pled
Deponida
29-11-2012
Registrada
22-03-2013
Publitgada
22-03-2013
Stizzada
22-06-2023
Motiv
Betg prolungada
Lingua da la procedura
franzos
Funtauna
Swissreg

Products e servetschs

Medical devices

Leer verkaufte Injektionsvorrichtungen für den Gebrauch bei der Behandlung von Multipler Sklerose.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 22-06-2023

    Stritgà, betg prolungà

    Published in Swissreg on 22.06.2023

  2. 01-05-2023

    Represchentant stritgà

    Representative
    WEINMANN ZIMMERLI, Apollostrasse 2, Postfach 1021, 8032 Zürich (allontanà)

    Published in Swissreg on 01.05.2023

  3. 01-05-2023

    Represchentant inscrit

    Representative
    Novagraaf Switzerland SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 01.05.2023

  4. 10-12-2013

    Represchentant inscrit

    Representative
    Zimmerli, Wagner & Partner AG, Apollostrasse 2, Postfach 1021, 8032 Zürich → WEINMANN ZIMMERLI, Apollostrasse 2, Postfach 1021, 8032 Zürich

    Published in Swissreg on 10.12.2013

  5. 22-03-2013

    Registrà

    Published in Swissreg on 22.03.2013

Partidas

Possessura

TEVA Pharmaceutical Industries Limited

Science Based Industries Campus Har Hotzvim P.O. Box 1142, Jerusalem 91010, IL

Represententa

Novagraaf Switzerland SA

Chemin de l'Echo 3, 1213 Onex

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.